Christchurch nutraceuticals company Waitaki Biosciences is starting to reap the benefits of a heavy investment into new processing facilities and its own branded product range as it readies to launch into China.
Waitaki is the trading arm of PharmaZen, which is listed on the Unlisted Securities
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
